Shanghai VKEY Biotechnologies Co., Ltd.

VKEY-BIO, founded in 2019, is a biotechnology company dedicated to the research and production of reagents for life sciences.  Recognized as a "High-Tech Enterprise," an "Innovative SME," and a "Technology-Based SME" in China, our focus is on providing high-quality reagents.  Our mission is to contribute to the reduction of drug discovery costs by offering comprehensive and customized solutions for your research.

Our products primarily based on Luminescent and TR-FRET technology platforms, designed for drugs screening and validation purposes.  Notably, our independently developed KeyTec® TR-FRET technology employs the stable energy donor (Solar Eu/Tb) and the stable energy acceptor (LA/HX) in a time-resolved fluorescence resonance energy transfer system.  TR-FRET is known for its ease of use, homogeneity (no wash), low background, wide range and robustness.